Refractory Chronic Lymphocytic Leukemia: Clinical Trials

3 trials for Refractory Chronic Lymphocytic Leukemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 unknown. 3 Phase 1, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 13Unknown 3
Phase 23Unknown 3

Follow Refractory Chronic Lymphocytic Leukemia: new trials by email Literature Review of Refractory Chronic Lymphocytic Leukemia trials Research Report on Refractory Chronic Lymphocytic Leukemia

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Treatment of Relapsed and/or Chemotherapy Refractory B-cell Malignancy by Tandem CAR T Cells Targeting CD19 and CD22
anti-CD19/22-CAR vector-transduced T cells - Hematopoietic/Lymphoid Cancer, Adult Acute Lymphoblastic Leukemia in Remission
Phase 1 / Phase 2UnknownChinese PLA General Hospital302017-08-012019-04-17
Competitive Transfer of αCD19-TCRz-CD28 and αCD19-TCRz-CD137 CAR-T Cells for B-cell Leukemia/Lymphoma
anti-CD19 CAR-T, Fludarabine, Cyclophosphamide - Hematopoietic/Lymphoid Cancer, Adult Acute Lymphoblastic Leukemia in Remission
Phase 1 / Phase 2UnknownThe Second Affiliated Hospital of Henan University of Traditional Chinese Medicine202016-02-012017-03-16
Genetically Engineered Lymphocyte Therapy in Treating Patients With Lymphoma That is Resistant or Refractory to Chemotherapy
anti-CD20-CAR vector-transduced autologous T cells, genetically engineered lymphocyte therapy - Hematopoietic/Lymphoid Cancer, Adult Acute Lymphoblastic Leukemia in Remission
Phase 1 / Phase 2UnknownChinese PLA General Hospital502013-01-012015-09-29

Narrower conditions

Hematologic Neoplasms (3)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (3)  ·  Lymphoma, Follicular (3)  ·  Lymphoma, Large B-Cell, Diffuse (3)  ·  Lymphoma, Mantle-Cell (3)  ·  Leukemia, Prolymphocytic (2)  ·  Disease (1)

Broader conditions

Chronic Disease (3)  ·  Disease Attributes (3)  ·  Hematologic Diseases (3)  ·  Hemic and Lymphatic Diseases (3)  ·  Immune System Diseases (3)  ·  Immunoproliferative Disorders (3)  ·  Leukemia (3)  ·  Leukemia, B-Cell (3)  ·  Leukemia, Lymphoid (3)  ·  Lymphatic Diseases (3)  ·  Lymphoma (3)  ·  Lymphoma, B-Cell (3)  ·  Lymphoma, Non-Hodgkin (3)  ·  Lymphoproliferative Disorders (3)  ·  Neoplasms (3)

Interventions

Cyclophosphamide (1)  ·  fludarabine (1)

Sponsors

Chinese PLA General Hospital (2)  ·  The Second Affiliated Hospital of Henan University of Traditional Chinese Medicine (1)

Countries

China (3)

Top investigators

Zhi Cheng, M.D. (1)

Results publications

PMID 25444722, PMID 29263894, PMID 32245502, PMID 34515338